Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

Shares of Merck & Co. Inc. MRK inched 0.44% higher to $101.17 Thursday, on what proved to be an all-around mixed trading ...

There simply isn't any one program in Merck's late-stage pipeline that has a similarly massive addressable market. That makes ...

On Tuesday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $101.65 which represents a decrease of $-0.22 or -0.22% from the prior close of $101.87. The stock opened at $101.36 and touched ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

With a market cap of $258 billion ... related charge impacting operating margins have further pressured Merck's stock performance. Moreover, despite reporting better-than-expected Q3 adjusted ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $101.88 which represents a decrease of $-0.44 or -0.43% from the prior close of $102.32. The stock opened at $101.78 and touched ...

There simply isn't any one program in Merck's late-stage pipeline that has a similarly massive addressable market. That makes ... looking for from a big pharma stock. Despite the upcoming headwind ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Pharmaceutical giant Bristol Myers Squibb (BMY) raises its full-year earnings guidance after topping third quarter estimates, ...

In my view, based on what's coming up for Merck, it's likely that investors with some patience will find the stock to be more ... it is guaranteed that its market share will dwindle due to ...